Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 6, 2005
A review on the role of antioxidants in the management of diabetes and its complicationsRoja Rahimi, Shekoufeh Nikfar, Bagher Larijani, et al.
Expert Opinion on Investigational Drugs|June 25, 2014
Phase II drugs under clinical investigation for the treatment of chronic constipationShilan Mozaffari, Tina Didari, Shekoufeh Nikfar, et al.
Expert Opinion on Drug Discovery|August 5, 2020
Drug discovery strategies for modulating oxidative stress in gastrointestinal disordersTaraneh Mousavi, Nastaran Hadizadeh, Shekoufeh Nikfar, et al.
Digestive Diseases and Sciences|August 7, 2008
Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysisRoja Rahimi, Shekoufeh Nikfar, Ali Rezaie, et al.
World Journal of Gastroenterology|April 3, 2009
Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysisRoja Rahimi, Shekoufeh Nikfar, Ali Rezaie, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 20, 2023
Common gastrointestinal drug-drug interactions in geriatrics and the importance of careful planningShilan Mozaffari, Taraneh Mousavi, Shekoufeh Nikfar, et al.
Archives of Medical Science : AMS|February 29, 2012
A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosisShekoufeh Nikfar, Roja Rahimi, Ali Rezaie, et al.
Clinical Therapeutics|March 1, 2011
Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitisShekoufeh Nikfar, Solmaz Ehteshami-Ashar, Roja Rahimi, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 13, 2015
Influence of ascorbic acid supplementation on type 2 diabetes mellitus in observational and randomized controlled trials; a systematic review with meta-analysisOzra Tabatabaei-Malazy, Shekoufeh Nikfar, Bagher Larijani, et al.
Expert Review of Anticancer Therapy|August 28, 2015
Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanomaElnaz Faghfuri, Mohammad Ali Faramarzi, Shekoufeh Nikfar, et al.
Pageof 20